TXMD
TherapeuticsMDBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
TXMD vs peer average
76/100
TXMD vs. peer average (B vs. D)
Grade spread
A 1 · B 1 · C 2 · D 3 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ATOS is the first available peer comparator.
Loose micro-cap biotech comparator; useful mainly for event volatility, not operating-model read-through.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TXMD
TherapeuticsMD
ATOS
Atossa Therapeutics
Grade
B
D
Momentum
86
2
Value
53
59
Sentiment
54
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs ATOS
TXMD / ATOS
Grade Position
Above peers
TXMD vs. peer average (B vs. D)
76/100
Momentum
86
TXMDValue
53
ATOSSentiment
54
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TXMD
ATOS is the first peer returned for this comparison set.